Valuation: IRADIMED CORPORATION

Market Cap 106.72Cr 97Cr 90Cr 81Cr 152.95Cr 9.97TCr 158.98Cr 1.09TCr 429.61Cr 5.38TCr 400.36Cr 391.97Cr 17TCr P/E 2026 *
43.6x
P/E 2027 * 37.4x
Enterprise Value 106.72Cr 97Cr 90Cr 81Cr 152.95Cr 9.97TCr 158.98Cr 1.09TCr 429.61Cr 5.38TCr 400.36Cr 391.97Cr 17TCr EV / Sales 2026 *
11.6x
EV / Sales 2027 * 10.4x
Free-Float
64.76%
Yield 2026 *
-
Yield 2027 * -
1 day-1.10%
1 week-4.64%
Current month+7.67%
1 month-5.81%
3 months-5.70%
6 months-6.71%
Current year-15.13%
1 week 82.08
Extreme 82.08
87.46
1 month 76.35
Extreme 76.35
89.48
Current year 76.35
Extreme 76.35
107.9
1 year 76.35
Extreme 76.35
107.9
3 years 40.05
Extreme 40.05
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Chairman 72 16/06/2020
Director/Board Member 70 01/01/2019
Director/Board Member 73 01/01/2014
Date Insider Type Main position Quantity % Market Cap. Importance
23/09/26 Exercice

Director

1,396 0.0109%
03/09/26 Sell

Director

-1,419 0.0111%
04/06/26 Sell

Director

-3,000 0.0235%
Change 5-day change 1-year change 3-year change Capi.($)
-1.10%-4.64%-4.20%+92.31% 106.72Cr
+0.92%-3.42%+20.33%+47.78% 25TCr
+1.38%-2.64%+1.59%+8.57% 16TCr
-0.89%-5.04%-21.93%+37.10% 15TCr
+1.59%-3.04%-55.90%-19.65% 6.24TCr
-0.24%-0.61%+25.13%+56.51% 6.06TCr
+1.25%+0.74%+5.46%-12.32% 5.3TCr
+2.50%-0.21%+22.75%+54.91% 4.86TCr
-3.26%-8.36%+2.04%+56.29% 4.67TCr
+3.54%-1.09%+23.67%+78.50% 4.42TCr
Average +0.57%-2.24%+1.90%+40.00% 9TCr
Weighted average by Cap. +0.68%-2.99%+3.10%+33.52%

Financials

2026 *2027 *
Net sales 9.22Cr 8.41Cr 7.77Cr 7.02Cr 13Cr 861.57Cr 14Cr 94Cr 37Cr 465.04Cr 35Cr 34Cr 1.47TCr 10Cr 9.33Cr 8.63Cr 7.79Cr 15Cr 956.27Cr 15Cr 104.22Cr 41Cr 516.15Cr 38Cr 38Cr 1.63TCr
Net income 2.46Cr 2.24Cr 2.07Cr 1.87Cr 3.52Cr 229.57Cr 3.66Cr 25Cr 9.89Cr 123.91Cr 9.22Cr 9.02Cr 391.27Cr 2.88Cr 2.63Cr 2.43Cr 2.19Cr 4.13Cr 269.13Cr 4.29Cr 29Cr 12Cr 145.26Cr 11Cr 11Cr 458.7Cr
Net Debt - -
Projected Income Statement - Annual - IRADIMED CORPORATION
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
19/26/19 $82.30 -1.38% 33,488
17/26/17 $83.45 -1.64% 85,461
16/26/16 $84.84 -0.60% 82,775
13/26/13 $85.35 +0.14% 1,15,214
12/26/12 $85.23 -1.56% 71,654
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
MarketScreener Ratings - IRADIMED CORPORATION
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
83.45USD
Average target price
118.00USD
Spread / Average Target
+41.40%
  1. Stock Market
  2. Stocks
  3. IRMD Stock